Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bayer
The study has previously been posted by Schering AG, Germany. Schering AG, Germany has been renamed to Bayer Schering Pharma AG, Germany.Bayer Schering Pharma AG, Germany is the sponsor of the trial.
Age
20–74
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Platelet counts of \>/= 100,000/mm3
Absolute neutrophil counts of \>/= 1,200/mm3
Bone marrow involvement \< 25%
You may not be if
Patients who received hematopoietic stem cell transplantation, including bone marrow transplantation, peripheral blood stem cell transplantation, etc.
Patients presenting with marked bone marrow hypocellularity (any suspected bone marrow hypocellularity should be confirmed by bone marrow biopsy)
Patients with previous myocardial infarction within the past 1 year, with heart disease that requires treatment or with pulmonary dysfunction
Patients with serious concomitant diseases (cardiac failure, renal failure, etc.)
Clareo Health | Study for Evaluation of Efficacy and Safety of SH L 749 to Indolent B-cell Non-Hodgkin's Lymphoma
